Newborn Screening for Congenital Adrenal Hyperplasia (CAH): Improving the Effectiveness of the Neonatal 17OH-Progesterone (N17OHP) and Serum Confirmatory Tests

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPCARVALHO, D.HAYASHI, G.MIRANDA, M.GAMES, L.MADUREIRA, G.MENDONCA, B.BACHEGA, T.2017-03-092017-03-092015HORMONE RESEARCH IN PAEDIATRICS, v.84, suppl.2, p.7-7, 20151663-2818https://observatorio.fm.usp.br/handle/OPI/18306engrestrictedAccessNewborn Screening for Congenital Adrenal Hyperplasia (CAH): Improving the Effectiveness of the Neonatal 17OH-Progesterone (N17OHP) and Serum Confirmatory TestsconferenceObjectCopyright KARGEREndocrinology & MetabolismPediatrics1663-2826